![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TEXTBOOK AND PUBLICATION ERRATACorrection Notice: Ertapenem information in Handbook on Injectable Drugs,
(2/13/2007)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Drug |
Mfr |
Conc |
Mfr |
Conc |
Remarks |
Ref |
C/I |
Heparin sodium |
APP |
40 and 100 units/mLa |
ME |
10 mg/mLb |
Visually compatible with about 4% ertapenem loss by HPLC in 4 hr |
2487 |
C |
|
APP |
50 and 100 units/mLb |
ME |
10 mg/mLb |
Visually compatible with about 3% ertapenem loss by HPLC in 4 hr |
2487 |
C |
a Tested in dextrose 5%.
b Tested in sodium chloride 0.9%
The error is carried over to the cross-reference. In the fifth column from the left on page 855 of the printed volume of HID 14th ed. under the Ertapenem entry of the table, the concentration should be listed as “40 and 100 units/mL” and “50 and 100 units/mL.”
Drug |
Mfr |
Conc |
Mfr |
Conc |
Remarks |
Ref |
C/I |
Ertapenem |
ME |
10 mg/mLb |
APP |
40 and 100 units/mLa |
Visually compatible with about 4% ertapenem loss by HPLC in 4 hr |
2487 |
C |
|
ME |
10 mg/mLb |
APP |
50 and 100 units/mLb |
Visually compatible with about 3% ertapenem loss by HPLC in 4 hr |
2487 |
C |
aTested in dextrose 5%.
bTested in sodium chloride 0.9%.
We urge you to correct this error in all copies of HID 14th ed. immediately and to communicate it to others on your staff who may use the book.
200 Lakeside Drive, Suite 200, Horsham, PA 19044 © 2009 Institute for Safe Medication Practices. All rights reserved |
![]() Health On the Net Foundation |
![]() Health Impact Award |
